Skip to content

Blood-brain barrier disruption is involved in cognitive impairment of Parkinson's disease patients with type 2 diabetes

Invovlement of blood-brain barrier dysfunction in cognitive impairment of Parkinson's disease patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102965
Enrollment
Unknown
Registered
2025-05-22
Start date
2025-06-05
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

PD group with T2DM:None
PD group without T2DM:None

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Parkinson's disease patients with or without T2DM; 2) No gender limitation, age 18-80 (including 18 and 80 years old);

Exclusion criteria

Exclusion criteria: 1) a history of dementia; 2) a history of mental disorders or current treatment for mental illnesses, such as taking anxiolytics, antidepressants, mood stabilizers, antipsychotics and other drugs that may interfere with the assessment; 3) a history of drug abuse or dependence; 4) pregnant women; 5) severe physical illnesses that may interfere with the assessment; 6) contraindication to MRI scan; 7) declining to participate.

Design outcomes

Primary

MeasureTime frame
PD-CRS scores;Ktrans values and Vp values in different brain regions;The volumes of specific brain regions and cortical thickness;

Secondary

MeasureTime frame
Serum levels of soluble ICAM-1?VCAM-1 and S100B;

Countries

China

Contacts

Public ContactJieping Lu

The First Affiliated Hospital of University of Science and Technology of China

lujp1984@163.com+86 551 62284084

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026